Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Zhejiang Chimin Pharmaceutical

The pharmaceutical and biological industry has a net outflow of 1.464 billion yuan today, and 7 shares have a net outflow of more than 100 million yuan.

  • Post date May 9, 2022 — 18:53 Post Lock Login to View

Read More

21 shares were sold at a low price by a large amount at a 24% discount- CFi.CN Zhongcai Network

  • Post date May 6, 2022 — 23:15 Post Lock Login to View

Read More

21 shares were sold at a low price by a large amount at a 24% discount- CFi.CN Zhongcai Network

  • Post date May 6, 2022 — 23:15 Post Lock Login to View

Read More

21 shares were sold at a low price by a large amount at a 24% discount- CFi.CN Zhongcai Network

  • Post date May 6, 2022 — 23:15 Post Lock Login to View

Read More

Shanghai Stock Exchange Block Trading Information on May 6

  • Post date May 6, 2022 — 21:21 Post Lock Login to View

Read More

21 shares were sold at a minimum of 26% at low prices-

  • Post date May 6, 2022 — 21:15 Post Lock Login to View

Read More

21 shares were sold at a low price by a large amount at a 24% discount- CFi.CN Zhongcai Network

  • Post date May 6, 2022 — 21:15 Post Lock Login to View

Read More

21 shares were sold at a low price by a large amount at a 24% discount- CFi.CN Zhongcai Network

  • Post date May 6, 2022 — 20:37 Post Lock Login to View

Read More

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks’ revenue and net profit will double, and BeiGene will become the “loss king” – yqqlm

  • Post date May 1, 2022 — 04:00 Post Lock Login to View

Read More

Over 60% of pharmaceutical companies will see net profit growth in 2021, and the pace of approval and listing of innovative drugs will continue to accelerate_Shenzhen Hotline

  • Post date April 30, 2022 — 14:14 Post Lock Login to View

Read More

Over 60% of pharmaceutical companies will grow in net profit in 2021, and the pace of approval and listing of innovative drugs will continue to accelerate

  • Post date April 30, 2022 — 11:43 Post Lock Login to View

Read More

OPCONTV rose more than 16.10%, and the healthcare ETF (516790) rose more than 2.97% – yqqlm

  • Post date April 27, 2022 — 18:54 Post Lock Login to View

Read More

4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm

  • Post date April 25, 2022 — 18:15 Post Lock Login to View

Read More

73 shares received a large amount of leveraged funds to increase positions

  • Post date April 25, 2022 — 10:40 Post Lock Login to View

Read More

The main capital of 4.355 billion yuan is withdrawn from the pharmaceutical and biological sector today – yqqlm

  • Post date April 20, 2022 — 18:36 Post Lock Login to View

Read More

4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm

  • Post date April 19, 2022 — 19:09 Post Lock Login to View

Read More

4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews

  • Post date April 19, 2022 — 18:12 Post Lock Login to View

Read More

Leveraged funds bucked the market and Masukura 78 shares CFi.CN Zhongcai Network

  • Post date April 18, 2022 — 14:35 Post Lock Login to View

Read More

ESG Weekly Report (Issue 34)丨Douban cooperates to rectify the chaos in the "rice circle" and closes multiple groups, and Snow Beer's subsidiary company is fined for excessive pollution discharge – yqqlm

  • Post date April 18, 2022 — 13:24 Post Lock Login to View

Read More

ESG Weekly Report (Issue 34)丨Douban cooperates to rectify the chaos of "rice circle" and closes multiple groups, and Snow Beer's subsidiary company was fined for excessive pollution discharge 21 Economic Net

  • Post date April 18, 2022 — 13:18 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.